Revisiting Screening in Women With a Family History of Breast Cancer.

breast cancer contrast-enhanced mammography familial risk magnetic resonance imaging (MRI) mammography screening ultrasound

Journal

Journal of breast imaging
ISSN: 2631-6129
Titre abrégé: J Breast Imaging
Pays: United States
ID NLM: 101752190

Informations de publication

Date de publication:
30 Nov 2023
Historique:
received: 31 05 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: ppublish

Résumé

Women with a family history (FH) of breast cancer and without known genetic susceptibility represent a unique population whose lifetime probability of developing breast cancer varies widely depending on familial factors, breast density, and the risk assessment tool used. Recently updated guidelines from the American College of Radiology recommend supplemental annual screening with contrast-enhanced MRI or contrast-enhanced mammography for women with an FH who are high risk (≥20% lifetime risk) or have dense breasts. To date, most screening studies addressing outcomes in women with FH have largely included those also with confirmed or suspected gene mutations, in whom the lifetime risk is highest, with limited data for women at average to intermediate risk who are not known to be genetically susceptible and may not benefit as much from the same screening approaches. Further research focusing specifically on women with FH as the only breast cancer risk factor is warranted to refine risk assessment and optimize a multimodality personalized screening approach.

Identifiants

pubmed: 38141237
pii: 7329706
doi: 10.1093/jbi/wbad069
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-645

Informations de copyright

© Society of Breast Imaging 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Kristen Coffey (K)

Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, NY, USA.

Victoria Mango (V)

Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, NY, USA.

Classifications MeSH